Harbour BioMed In March 2025, AstraZeneca executed a global strategic collaboration with Harbour BioMed to discover and develop next-generation multi-specific antibodies for immunology ...

Some of the investment is also earmarked for research and manufacturing agreements, which include three new alliances with Chinese biotechs Harbour BioMed, Syneron Bio, and BioKangtai. Those come ...

The antibody, called WIN378, has been licensed from China's Kelun Biotech and Harbour BioMed and has the potential to be dosed every six months. That could differentiate it from Amgen and ...

Miscellaneous28.04.2025 / 14:04 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket ...

Miscellaneous29.04.2025 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement. Mainz Biomed Enters into Technology Partnership with EDX Medical GroupBERKELEY, US and ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the ...

During her first full hearing as committee chairwoman, Republican Sen. Susan Collins of Maine also said the Trump ...

About 100 undergrads and 40 graduate students gathered to present their research findings, exchange ideas and network with ...

MDI Biological Laboratory in Bar Harbor gets federal funding to support it’s research on Aging, regeneration and ...

Mainz Biomed N.V. (NASDAQ: MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of ...

Mainz Biomed signed a license and option agreement ... “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act ...

Mainz Biomed signed a license and option agreement with Liquid Biosciences ... Certain statements made in this press release are "forward-looking statements” within the meaning of the "safe harbor” ...